AI Terminal
Assura PLC
Director's Dealing • Oct 19, 2020
4924_dirs_2020-10-19_1c78586b-d138-4cf0-a4fb-ef33e43bc93a.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 5004C
Assura PLC
19 October 2020
19 October 2020
Assura plc
("the Company")
Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")
The Company has been notified that in respect of the interim dividend paid on 14 October 2020, the following PDMRs acquired ordinary shares of 10 pence each in the Company through their participation in the Company's Scrip Dividend Alternative:
| PDMR | Date Acquired | Number of shares acquired | Purchase price per Share |
| Ed Smith | 14 October 2020 | 680 | £0.79 |
| Jayne Cottam | 14 October 2020 | 1,073 | £0.79 |
The Notification of Dealing Form for Mr Smith and Mrs Cottam can be found below.
This notification is made in accordance with the Market Abuse Regulation.
-ENDS-
Notification of dealing form
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Ed Smith
2
Reason for the notification
a)
Position/status
Chairman
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Purchase of shares under the Scrip Dividend Alternative
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.79 GBP | 680 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.79 GBP | 680 | £537.20 GBP |
e)
Date of the transaction
14 October 2020
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jayne Cottam
2
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Purchase of shares under the Scrip Dividend Alternative
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.79 GBP | 1,073 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.79 GBP | 1,073 | £847.67 GBP |
e)
Date of the transaction
14 October 2020
f)
Place of the transaction
XLON
For more information, please contact:
| Assura plc | Tel: 01925 420680 |
| Orla Ball, Company Secretary David Purcell, Head of Financial Reporting |
Email: [email protected] |
| Finsbury Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBBBDGGBBDGGC